جست‌وجوی استاد و پژوهشگر

Frederik Dammمشاهده پروفایل

استاد

• Hematology
• Oncology
• Tumor Immunology
• +۵ مورد دیگر

Prof. Dr. med. Frederik Damm is a Professor and Managing Senior Physician at the Department of Hematology, Oncology and Cancer Immunology at Charité – University Medicine Berlin (Campus Virchow-Klinikum). He serves as Director of the Molecular Cancer Research Center (MKFZ) and leads research initiatives in clonal hematopoiesis, leukemia genomics, and immunotherapeutic applications. Primary Affiliation: Charité – University Medicine Berlin Leadership: Director of the Molecular Cancer Research Center (MKFZ) Research Focus: Dr. Damm investigates clonal hematopoiesis, tumor heterogeneity in AML and lymphomas, and therapeutic resistance mechanisms. His work integrates genomic profiling, epigenetics, and machine learning for outcome prediction in hematologic malignancies. Article Trends: Recent publications emphasize clonal evolution in cancers, CAR T-cell therapy applications across hematologic and autoimmune diseases, and genomic aberrations in AML and lymphomas. Collaborative efforts with the HARMONY Alliance highlight big data approaches to refine treatment strategies. Technical Networks: Dr. Damm collaborates with the HARMONY Alliance and contributes to precision oncology through next-generation sequencing, CRISPR modeling, and international clinical trial datasets.

Lori Lewisمشاهده پروفایل

پژوهشگر

• Body Composition
• Lymphoedema
• Breast Cancer
• +۵ مورد دیگر

Lori Lewis is a Senior Research Officer at the ALERT (Australian Lymphoedema Education, Research, and Treatment) Centre within Macquarie University's Department of Health Sciences. She specializes in lymphoedema research, prospective surveillance for breast cancer-related complications, and clinical trials coordination. Education: Bachelor of Science in Physiotherapy (Curtin University, 1991), Master of Research (Macquarie University, 2024) Certifications: ALERT Level 1 Lymphoedema Accreditation (2020) Her research focuses on body composition analysis, chemotherapy toxicity management, and compression therapy applications in oncology settings. Collaborations with multidisciplinary teams at MQ Health Lymphoedema Clinic involve diagnostic, surgical, and lipoedema clinics. Recent research outputs include systematic reviews on breast cancer chemotherapy toxicities and case studies on radiotherapy-related edema management, covering disciplines like oncology, physiotherapy, and dermatological radiation effects. Key responsibilities include protocol writing, ethics applications, and clinical trial coordination. She engages in international collaborations and maintains active contributions to peer-reviewed publications.

• Implant Medicine
• Prosthesis
• Head and Neck Cancer
• +۵ مورد دیگر

Dr. Harry Reintsema is a researcher specializing in implant medicine, prosthetics, and rehabilitation engineering for head and neck cancer patients. His work intersects oncology, dentistry, and biomedical engineering, focusing on improving prosthetic rehabilitation outcomes and radiation therapy techniques. Research Interests: Active in advancing zygomatic implant placement, 3D-guided surgical protocols, and prosthetic solutions for maxillectomy patients. His studies address challenges in radiation therapy dosing, trismus treatment, and post-surgical functional recovery. Key Research Trends: Recent publications emphasize Comparative efficacy of proton vs. photon radiation therapy 3D surgical navigation accuracy Immediate prosthetic obturation techniques Rehabilitation engineering for jaw mobility Citations & Impact: His 2023 article on Oral Oncology received 4 citations, while the 2022 review in Journal of Personalized Medicine was cited 16 times. Open-access availability amplifies his work's reach through Mendeley and social media engagement.

Zhongming Zhangمشاهده پروفایل

استادیار

• Neutron detection
• Semiconductor neutron detectors
• Monte Carlo simulation
• +۳ مورد دیگر

Dr. Zhongming Zhang is an International Lecturer (Assistant Professor) at Lancaster University's School of Engineering, Department of Engineering. He is affiliated with the Lancaster University College at Beijing Jiaotong University (LUC-BJTU), a joint institute established near Weihai, Shandong province, China, where he teaches undergraduate modules for the Electronics and Communications Engineering degree programme. Dr. Zhang's educational background includes: PhD in Engineering from University of Lancaster MSc in Physics and Technology of Nuclear Reactors from University of Birmingham BEng in Radiation Protection and Nuclear Safety from Lanzhou University His research focuses on developing neutron detectors for extreme detection environments, with particular expertise in semiconductor neutron detectors and analyzing signals in extreme environments where intense noise can severely affect pulse readings. Dr. Zhang's work bridges nuclear engineering with materials science and computational methods, with growing interest in blockchain applications for nuclear engineering problems. His research spans detector material development, signal processing in high-noise environments, and innovative applications of distributed ledger technology in nuclear sectors. Analysis of Dr. Zhang's recent publications shows a consistent focus on neutron detection technologies, with particular emphasis on boron-based materials and semiconductor detectors. His work spans materials science, detector design, and simulation techniques, with increasing exploration of blockchain applications in nuclear engineering. The research demonstrates a progression from fundamental materials development to practical applications in nuclear detection systems. Dr. Zhang actively welcomes students interested in research collaboration, as well as visiting scholars and faculty members who wish to apply for academic visits. He is currently teaching several undergraduate modules including Computers and Control, Fundamentals of Digital Electronics, Digital Electronics, and supervising Individual BEng Projects. Dr. Zhang has been involved in research projects including "Research on key technologies of boron-10 nitride neutron detecting material growth and device fabrication" (2022-2024) and has participated in numerous nuclear science conferences including IEEE Nuclear Science Symposium and Medical Imaging Conference.

• Intensity Modulated Radiation Therapy (IMRT)
• Image-Guided Adaptive Radiation Therapy (IGART)
• Magnetic Resonance Imaging (MRI)
• +۳ مورد دیگر

Dr. Nesrin Dogan is a Professor, Vice Chair, and Chief of the Medical Physics Division at the University of Miami Miller School of Medicine's Department of Radiation Oncology. She is board-certified by the American Board of Radiology in Therapeutic Radiologic Physics and has led pioneering work in MR-guided radiotherapy (MRgRT), intensity-modulated radiation therapy (IMRT), and radiomics. Ph.D. in Nuclear Engineering, University of Michigan (1993) Postdoctoral Fellowship, University of Michigan Radiation Oncology (1995) Her research focuses on image-guided adaptive radiation therapy (IGART), deformable image registration, and radiomics for predicting treatment response in pancreas and liver cancers. Her recent publications highlight advancements in MR-LINAC imaging, radiomic feature analysis, and adaptive proton therapy. She has established CAMPEP accreditation for the University of Miami's Medical Physics Residency Program and directed clinical implementations of HyperArc, proton therapy, and MRgRT systems. Fellow of the American Association of Physicists in Medicine (AAPM) Recipient of the University of Michigan Rackham Barbour Scholarship American Board of Radiology Certification Dr. Dogan mentors medical physics residents and graduate students, co-directs the CAMPEP-accredited Medical Physics Graduate Program, and serves as an editor for Frontiers in Oncology . Her leadership roles in AAPM, CAMPEP, and ASTRO committees underscore her impact on radiation oncology standards and education.

Abdurahman Kuzhanمشاهده پروفایل

استادیار

• Radiation Oncology
• Cancer Research
• Breast Cancer
• +۴ مورد دیگر

Abdurahman Kuzhan is an Assistant Professor in the Department of Internal Medical Sciences at Gaziantep University's Faculty of Medicine, serving since 2023. Previously, he held equivalent positions at Pamukkale University (2021-2023) and Gaziantep University during earlier periods (2013-2016, 2010-2013), beginning his academic career as a Research Assistant (2006-2010). His educational background includes: Specialization in Radiation Oncology (2006-2010), Gaziantep University Faculty of Medicine Medical Degree (1992-2000), Gaziantep University Faculty of Medicine Dr. Kuzhan's research centers on Radiation Oncology with emphases on breast, gastric, and endometrial cancers. He investigates socioeconomic determinants of cancer outcomes, radioprotective agents (propolis, Nigella sativa), and dosimetric comparisons of radiotherapy techniques. His work bridges clinical applications, biological mechanisms, and health disparities. Recent publications (2022-2023) reveal trends in personalized radiotherapy approaches, biomarker-driven treatment response prediction (particularly FDG PET for bone metastases), and sociocultural influences on cancer prognosis. Key themes include optimizing radiotherapy protocols for gastrointestinal and gynecological cancers while addressing accessibility barriers. He has supervised two theses: Derya Çağlayan (2016): Socioeconomic factors in young breast cancer patients Kudret Bektaş (2016): Dosimetric comparisons in gastric cancer radiotherapy Dr. Kuzhan is an active member of the Turkish Radiation Oncology Association since 2013 and teaches graduate courses in Radiation Physics, Radiobiology, and Dosimetry.

Susan A. McCloskeyمشاهده پروفایل

استادیار

• Radiation Oncology
• Breast Cancer
• Quality of Care
• +۳ مورد دیگر

Dr. Susan A. McCloskey is an Assistant Professor of Radiation Oncology at the University of California, Los Angeles (UCLA) and serves as the Santa Monica Breast Cancer Medical Director. She is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center.

Jason Liuمشاهده پروفایل

استادیار بالینی

• Radiation Oncology
• Cancer Treatment
• Radiotherapy
• +۲ مورد دیگر

Jason Liu, M.D., is a Clinical Assistant Professor in the Department of Radiation Oncology at City of Hope, practicing at both South Pasadena and Glendale Radiation Oncology Centers. He specializes in intensity-modulated radiation therapy, stereotactic ablative radiotherapy, and radiosurgery for gastrointestinal, prostate, lung, breast, head and neck, rectal, hepatobiliary, and gynecologic cancers. Education: Doctor of Medicine (2019), Pennsylvania State College of Medicine, Hershey, Pennsylvania Residency in Radiation Oncology (2024), City of Hope, Duarte, California Preliminary Internal Medicine Internship (2020), Einstein Medical Center, Philadelphia, Pennsylvania Dr. Liu’s research focuses on bridging real-world clinical practices with standard-of-care protocols, particularly in advanced lung cancer treatment disparities. His clinical work emphasizes personalized, multidisciplinary care for cancer patients. Scientific Awards: International Association for the Study of Lung Cancer (IASLC) Early Career Award (2021) Trainee of the Year (2024), City of Hope Residency Program With over 50 peer-reviewed publications and abstracts, Dr. Liu is committed to advancing cancer care while fostering patient-centered environments. He currently serves as Assistant Clinical Professor, contributing to both clinical practice and academic research at City of Hope.

Liyuan Chenمشاهده پروفایل

استادیار

• Medical Image Reconstruction
• Medical Image Processing
• Inverse Treatment Planning
• +۳ مورد دیگر

Liyuan Chen, Ph.D., is an Assistant Professor in the Department of Radiation Oncology at the University of Texas Southwestern Medical Center. She earned her doctorate from Hong Kong Baptist University and completed postdoctoral training followed by a clinical residency in UT Southwestern's Medical Physics Residency Program, where she served as chief resident during her second year. Her research focuses on computational approaches in radiation oncology, including: Advanced medical image reconstruction and processing techniques Inverse treatment planning optimization methods Machine learning models for treatment outcome prediction Deep learning applications in cancer imaging and radiotherapy Adaptive radiotherapy protocol development Dr. Chen's recent publications (2020-2025) demonstrate strong emphasis on artificial intelligence applications in oncology, particularly deep learning models for medical image analysis, treatment planning automation, and predictive oncology. Her work consistently addresses clinical challenges in head and neck cancer, lung malignancies, and prostate cancer radiotherapy through innovations in convolutional neural networks, reinforcement learning frameworks, and adaptive treatment protocols.

• Medical Physics
• Radiation Oncology
• Particle Therapy
• +۱۲ مورد دیگر

Hao Peng is a Professor in the Department of Medical Physics at the University of Texas Southwestern Medical Center (UTSW). He previously served as Director of the Medical Physics Program at Wuhan University, China, and completed postdoctoral training in the Department of Radiology at Stanford University. Dr. Peng holds a B.S. and M.S. from Wuhan University and a Ph.D. from the University of Western Ontario (Canada). His visiting professorships include Stanford University, McMaster University (Canada), and Hokkaido University (Japan). Current Position: Professor, UTSW Medical Physics Department Previous Roles: Director at Wuhan University, Visiting Professor at Stanford, McMaster, Hokkaido Education: B.S./M.S. (Wuhan), Ph.D. (Western Ontario) Dr. Peng’s research focuses on Medical Physics and Radiation Oncology , with applications of Machine Learning in particle therapy. Key areas include Proton Therapy , Radiation Dose Verification , and Radiation-Immunotherapy Synergy . He has pioneered computational frameworks like SWFT-Net and DiscoGAN for adaptive radiotherapy and developed simulation models for FLASH therapy and dose painting. Analysis of Dr. Peng’s 15 most recent publications reveals trends in: Proton Therapy : Dose verification, range monitoring, and adaptive techniques AI/ML Applications : Deep learning for treatment optimization, radiomics, and outcome prediction Radiation-Immunotherapy Synergy : Mathematical modeling of combined therapy effects Medical Imaging : Scintillation crystal design and PET scanner development

• Radiation Oncology
• Medical Physics
• Computational Physics
• +۵ مورد دیگر

Dr. Yulong Yan is a Professor in the Department of Radiation Oncology at UT Southwestern Medical Center, where he serves as Director of Computational Physics and faculty in the Division of Medical Physics & Engineering. His career spans academic, clinical, and technical domains in radiation oncology and biomedical engineering. Bachelor's & Master's: Nanjing University of Aeronautics and Astronautics Ph.D.: Biomedical Engineering, Southeast University, Nanjing Fellowship/Residency: Stanford University School of Medicine Dr. Yan's research focuses on Medical Physics , Adaptive Radiotherapy , and Deep Learning applications in clinical oncology. Key areas include: Functional lung avoidance techniques (FWAS, virtual bronchoscopy) Deep learning for synthetic CT generation and tumor segmentation Dose verification platforms (ART2Dose) Radiation toxicity modeling for brain and lung treatments Bluetooth-based localization systems for clinical applications MR-only radiotherapy workflows His publications demonstrate expertise in Image-Guided Radiotherapy , Treatment Planning Optimization , and Radiation Dose Modeling , with a 2013–2024 publication record showing sustained contributions to Medical Physics , Radiotherapy and Oncology , and PLOS One . Dr. Yan has served as Associate Editor for Medical Physics and Journal of Clinical Medical Physics , while chairing the Southwest Chapter AAPM Communications and IT Committee since 2014. As an educator since 2013, he mentors medical physics residents and postdoctoral fellows while delivering lectures in the Medical Physics Certificate Program.

Carla Rohrer Bleyمشاهده پروفایل

استاد

• Radiation Oncology
• Cancer Translational Research
• Radiation Biology
• +۶ مورد دیگر

Prof. Dr. Carla Rohrer Bley serves as a Professor in the Division of Radiation Oncology at the Vetsuisse Faculty, University of Zurich, where she leads the Radiation Oncology Group. This group operates one of Europe's most advanced veterinary cancer treatment facilities, delivering radiation therapy, chemotherapy, surgery, interventional radiology, immunotherapy, stereotactic radiosurgery, and intensity modulated radiotherapy using methodologies comparable to human oncology. Her research program integrates clinical practice with translational science across three interconnected domains: Radiation Biology: Investigating cellular DNA damage/repair kinetics and tissue-level radiation side effects, particularly in stereotactic hypofractionated radiotherapy regimens. Protocol Optimization: Developing and clinically validating radiotherapy protocols through NTCP (Normal Tissue Complication Probability) modeling to maximize tumor control while maintaining acceptable normal tissue toxicity levels. Translational Equipment Testing: Leveraging spontaneously occurring animal tumors as models for human cancer to evaluate innovative technologies like hyperthermia applicators in combination with radiotherapy, in collaboration with Kantonsspital Aarau and IT'IS Foundation. The Radiation Oncology Group functions as a critical bridge between veterinary and human medicine, utilizing naturally occurring tumors in immunocompetent animal models of human physiological scale to advance cancer therapies with direct translational potential to human patients.

Michael Nolanمشاهده پروفایل

استاد

• Cancer Biology
• Neurobiology
• Peripheral Nervous System
• +۵ مورد دیگر

Michael Nolan, DVM, PhD, DACVR is a Professor of Radiation Oncology in the Department of Clinical Sciences at North Carolina State University's College of Veterinary Medicine. He is also a member of the UNC Lineberger Comprehensive Cancer Center. Dr. Nolan is board-certified in veterinary radiology (DACVR) and holds a PhD in radiation and cancer biology. His research focuses on the complex intersection of cancer and neurobiology, with particular emphasis on the peripheral nervous system and pain signaling in the context of head and neck cancer. As the 2024 Randall B. Terry, Jr. Distinguished Professor of Oncology at NC State College of Veterinary Medicine, his work bridges veterinary and human medicine through comparative oncology approaches. Dr. Nolan's recent research has centered on stereotactic radiation therapy applications for various cancers in companion animals, including nasal tumors, brain tumors, and oral melanoma. His work demonstrates how advanced radiation techniques can improve tumor control while minimizing side effects in veterinary patients. He collaborates with institutions like Duke University through the Consortium for Canine Comparative Oncology to explore new cancer therapies with potential applications for both animals and humans. His laboratory investigates molecular mechanisms of radiation response, particularly examining how cancer/neuron interactions influence pain signaling and tumor progression. This research has implications for improving pain management in cancer patients while potentially enhancing treatment efficacy. Dr. Nolan has received recognition for his contributions to veterinary radiation oncology, most notably the 2024 Randall B. Terry, Jr. Distinguished Professorship. His work has advanced the field of veterinary radiation oncology through numerous publications on stereotactic radiation therapy protocols, radiation-induced pain mechanisms, and comparative cancer models. He is actively involved in clinical care, utilizing cutting-edge technology including the Varian Novalis TX linear accelerator with a Protura six-degrees-of-freedom treatment couch to deliver precise radiation treatments to animal patients. His clinical work focuses on delivering radiation via photons or electrons using both traditional and advanced techniques including stereotactic radiation therapy (SRT) and intensity-modulated radiation therapy (IMRT).

Michele Ferenciمشاهده پروفایل

دانشیار

• Radiation Therapy
• Medical Physics
• Brachytherapy
• +۳ مورد دیگر

Michele Ferenci, PhD serves as Associate Professor and Chief of Medical Physics within the Department of Radiation Oncology at Penn State Cancer Institute, part of Penn State University. Holding Diplomate status with the American Board of Radiology (DABR), Ferenci leads medical physics operations in a clinical radiation oncology setting, focusing on advanced radiotherapy techniques and quality assurance protocols. Ferenci's research spans radiation therapy physics with particular expertise in intensity-modulated radiation therapy (IMRT), brachytherapy applications, neutron dosimetry, and quality assurance methodologies. Key research areas include MRI-guided radiotherapy optimization, High Dose-Rate (HDR) brachytherapy procedures, and specialized radiation delivery systems for complex anatomical sites. The research fingerprint shows strong concentration in radiation therapy (85%), intensity-modulated radiation therapy (75%), and neutron dosimetry (75%). Recent publications reveal consistent scholarly output since 2003, with notable 2024 work on MRI-guided radiotherapy for thoracic tumors examining clinical factors affecting treatment efficiency. The publication record demonstrates specialization in technical radiotherapy aspects including IMRT QA, brachytherapy applicator digitization, and specialized radiation delivery systems. Research trends show progression from fundamental dosimetry work toward increasingly complex image-guided and specialized radiotherapy applications. Diplomate, American Board of Radiology (DABR) As Chief of Medical Physics, Ferenci oversees clinical physics operations including treatment planning, quality assurance, and radiation safety protocols. The position involves direct responsibility for medical physics staff and integration of advanced radiotherapy technologies into clinical practice. Research activities indicate collaboration with radiation oncologists, neurosurgeons, and medical physicists across multiple institutions, particularly evident in the Gamma Knife radiosurgery preclinical study and multi-institutional brachytherapy research.

Nicholas Potterمشاهده پروفایل

استادیار

• Radiation Oncology
• Medical Physics
• Dose Calculation
• +۴ مورد دیگر

Nicholas Potter, PhD is an Assistant Professor in the Department of Radiation Oncology with significant contributions to medical physics and radiation therapy techniques. His research focuses on improving the accuracy and safety of radiation treatment delivery systems. Dr. Potter's primary research interests include: Radiation Oncology Medical Physics Dose Calculation Intensity Modulated Radiation Therapy Flattening Filter Free Beams VMAT (Volumetric Modulated Arc Therapy) MRI-guided Radiotherapy His work demonstrates expertise in developing innovative approaches to radiation therapy challenges, with particular focus on sliding window techniques for dose calculation accuracy and beam modulation for flattening filter free photon beams. Dr. Potter has developed methods that address critical aspects of radiation therapy quality assurance and treatment planning. Dr. Potter's scientific impact includes: h-index of 39 7 research outputs between 2019-2024 Significant citations in key journals including Medical Physics (30 citations for his IMRT QA work) His research has practical applications across multiple areas of radiation oncology, particularly in MRI-guided radiotherapy for thoracic tumors, error detection in treatment quality assurance, and tumor phase recognition using imaging techniques to manage respiratory motion during treatment.